Midkine expression correlating with growth activity and tooth morphogenesis in odontogenic tumors
Introduction
Midkine (MK) is a low molecular weight heparin-binding growth factor. This cytokine is highly expressed in the mid-gestational period during embryogenesis. MK participates in cell growth, survival, migration, neurogenesis, and carcinogenesis. MK is involved also in morphogenesis of various organs through epithelial-mesenchymal interactions. [1] [2] [3] [4] [5] [6] In the morphogenesis of the tooth, enamel and dentin matrices are produced by ameloblasts and odontoblasts, respectively. Ameloblasts are derived from odontogenic epithelial elements, and odontoblasts differentiate from odontogenic ectomesenchymal tissue in the tooth germ. These epithelial and mesenchymal differentiations do not independently occur, but are induced through the intermediary interaction between odontogenic epithelial and ectomesenchymal components. [7, 8] Therefore, tooth germ is regarded as one of the good morphogenetic models for epithelial-mesenchymal interactions.
Mitsiadis et al. observed the regulation of MK gene and protein expression by
epithelial-mesenchymal interaction in the tooth germ, and suggested an important role for MK in the molecular cascade that controls tooth development. [9] The MK expression in odontogenic tumors has not been investigated. Odontogenic tumors are histologically divided by WHO into several categories, depending on their constituent components, as follows: [10] Benign 1) Tumors comprising odontogenic epithelium with mature, fibrous stroma without odontogenic ectomesenchyme 5 2) Tumors comprising odontogenic epithelium with odontogenic ectomesenchyme, with or without dental hard tissue formation 3) Tumors comprising mesenchyme and/or odontogenic ectomesenchyme with or without odontogenic epithelium Malignant 1) Odontogenic carcinomas 2) Odontogenic sarcomas Ameloblastoma, ameloblastic carcinoma, keratocystic odontogenic tumor, and adenomatoid odontogenic tumor are composed of odontogenic epithelium with mature, fibrous stroma without odontogenic ectomesenchyme. Ameloblastic fibroma and ameloblastic fibrosarcoma are tumors characterized by odontogenic epithelium with odontogenic ectomesenchyme, without dental hard tissue formation. Odontoma, ameloblastic fibrodentinoma, and ameloblastic fibro-odontoma are categorized as tumors comprised of odontogenic epithelium with odontogenic ectomesenchyme, with dental hard tissue formation. Almost all tumors possessing dental hard tissue formation contain neoplastic ameloblasts and/or odontoblasts associated with production of enamel and dentin matrices, respectively.
To investigate whether MK participates in the construction of characteristic histological structures in these tumors, we looked at their MK immunoexpression.
Materials and methods
We investigated 141 cases of human odontogenic tumors including ameloblastoma 6 (55), ameloblastic carcinoma (3), keratocystic odontogenic tumor (28) , adenomatoid odontogenic tumor (4), odontoma (compound type (24) and complex type (15) For the investigation of MK expression, we employed a mouse anti-human MK monoclonal antibody (TFB Inc., Tokyo, Japan) as the primary antibody. To evaluate the relationship with cell growth, a mouse anti-human proliferating cell nuclear antigen (PCNA) monoclonal antibody (DakoCytomation Co., Ltd., Kyoto, Japan) was applied after the retrieval of PCNA in 0.01 M citrate buffer (pH: 6.0) by heating (121ºC, 10 min) in an autoclave. Immunostaining was carried out using the EnVision + system (DakoCytomation).
The chromogen 3,3'-diaminobenzidine (Sigma-Aldrich Japan, Tokyo) was used to reveal the sites of peroxidase activity. After counterstaining the sections with hematoxylin, they were dehydrated and mounted in a synthetic mounting medium.
Results
A brief summary of the results is shown in Table 2 . 
Ameloblastoma
MK localization was found in 30 of 55 ameloblastomas (54.5%). The columnar epithelial cells at the periphery of the parenchyma, especially in cells projecting from epithelial nests, showed immunoreaction with MK in their cytoplasm. However, not all peripheral cells were uniformly positive; patchy positivity was observed in the periphery of the nests. Faint or absent expression were noted in the fibroblasts of the stroma (Fig. 1a ).
MK was expressed also in squamous metaplastic areas or the acanthomatous patterns of ameloblastoma, which were composed of epithelial cells with eosinophilic abundant cytoplasm suggesting keratinization ( Fig. 1b ). PCNA was frequently expressed in the nuclei of the peripheral columnar cells rather than the central cells. Particularly columnar cells in projections budding from the nests exhibited intense immunostaining for PCNA ( Fig. 1c ).
Ameloblastic carcinoma
Two of 3 ameloblastic carcinomas were positive for MK (66.7%), with localization in practically the entire peripheral columnar epithelium of tumor parenchyma.
Stroma showed no MK expression. There was no noticeable difference in positive rate and staining intensity between benign ameloblastomas and ameloblastic carcinomas.
Keratocystic odontogenic tumor
MK was expressed in 11 of 28 keratocystic odontogenic tumors (39.3%). We found intense reactivity in the neoplastic epithelium and exfoliated keratin (Fig. 2) .
Invaginated epithelium into the fibrous stroma from keratinized squamous epithelium lining the cyst wall, and epithelium of daughter cysts, showed immunolocalization. 8 
Adenomatoid odontogenic tumor
No MK expression was seen in the parenchyma and stroma in all cases.
Odontoma
We observed MK expression only in 1 of 24 compound type odontomas (4.2%) and 2 of 15 complex type odontomas (13.3%). There was no expression in dental hard tissues, reduced ameloblasts, differentiated pulp cells, and odontoblasts ( Fig. 3) , whereas small nodules of odontogenic ectomesenchymal tissue and round islands of odontogenic epithelium in the tumor had MK expression. The latter cellular components were not associated with production of dental hard tissues.
Ameloblastic fibroma
Immunoreactivity was stronger in all ameloblastic fibromas than ameloblastomas.
MK was expressed in follicular epithelial elements like the enamel organ of tooth germ and surrounding odontogenic ectomesenchymal tissue. The positive tumor cells exhibited cytoplasmic and nuclear reaction. The intensity of expression in the ectomesenchyme was weaker with increasing distance from the epithelial follicles ( Fig. 4a ). Basement membrane circumscribing epithelial follicles and some highly cellular areas of odontogenic ectomesenchyme were strongly MK positive (Fig. 4b ). PCNA was expressed both in epithelial and ectomesenchymal tissues. Especially, peripheral columnar cells were strongly positive, whereas the ectomesenchymal cells adjacent to the epithelial follicles infrequently showed reactivity to PCNA. In the ectomesenchymal area, highly cellular nodules demonstrated intense PCNA expression with distribution similar to that of MK (Fig. 4c ). 9 All ameloblastic fibrodentinomas and fibro-odontomas were positive for MK, and its distribution in areas without dental hard tissue formation was similar to that of ameloblastic fibroma. Participants in hard tissue production, including epithelial islands and ectomesenchymal cells adhering to or near the dental hard tissue, showed very faint or no expression of MK. Basement membrane around the epithelial elements in this hard tissue-producing area exhibited no expression ( Fig. 5 ).
Ameloblastic fibrodentinoma and fibro-odontoma

Ameloblastic fibrosarcoma
All ameloblastic fibrosarcomas showed strong MK expression in both the epithelial follicles and surrounding ectomesenchymal components. Although the ectomesenchymal tissues exhibited diffuse MK expression, no difference in intensity of MK expression was noted between ameloblastic fibroma and ameloblastic fibrosarcoma.
Discussion
MK is involved in carcinogenesis and cancer-related angiogenic, fibrinolytic, chemotactic, mitogenic, anti-apoptotic, and transforming activities. [1, 2, 4] Therefore, various carcinomas express MK, and serum MK level increases in some carcinomas including hepatocellular carcinoma and gastrointestinal carcinomas. [11] [12] [13] In the present study, there was no difference in positive rate or intensity of MK expression between benign odontogenic tumors and their malignant counterparts ( Table 2 ). These data suggest that MK cannot be used as a marker to distinguish malignant from nonmalignant odontogenic tumors.
Sandra et al. found immunohistochemical expression of MK in 70% of ameloblastoma cases and high MK labeling index in the outer cells of the parenchyma. [14]
They concluded that MK played an important role in the growth of ameloblastoma, after observing that the level of MK expression reflected the growth rate of ameloblastoma. We also preferentially detected MK expression in columnar epithelium projecting from the parenchyma of ameloblastomas. WHO defined solid/multicystic type ameloblastoma (conventional ameloblastoma) as a slowly growing, locally invasive, epithelial odontogenic tumor of the jaws with a high rate of recurrence if not removed adequately, but with virtually no tendency to metastasize. [15, 16] In addition to the epithelium with exfoliated keratin, MK expression was observed in invaginated epithelium from cyst wall and epithelium of daughter cysts.
These findings suggest that the expression profile of MK correlates with local aggressiveness and/or growth activity of keratocystic odontogenic tumors.
MK expression also correlates closely with morphogenesis of various organs
regulated through epithelial-mesenchymal interactions. [1] [2] [3] [4] [5] [6] Physiological morphogenesis and cell differentiation in tooth development are regulated by a series of epithelial-mesenchymal interactions. [7, 8, 17] Many transcription and signaling factors are associated with reciprocal interactions involved in tooth development. [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] Various odontogenic tumors histologically mimic the odontogenic tissues that participate in tooth development. Thus some factors involved in tooth development have been immunohistochemically revealed in odontogenic tumors. [28] [29] [30] [31] [32] [33] [34] Mitsiadis et al. [9] investigated MK expression in tooth development of mice and found that the distribution of MK expression depended on the developmental stage of the tooth germ. In the late bell stage without dental hard tissue formation, intense MK localization was found in the inner enamel epithelium, whole dental papilla, and the basement membrane between them. In contrast, in the late bell stage with dental hard tissue formation, MK expression was absent from all dental cells in the crown region. Therefore, inner enamel epithelium and differentiating ectomesenchymal cells showed MK localization, whereas MK localization in ameloblasts, odontoblasts, and pulp cells diminished after their terminal differentiation.
The distribution of MK in ameloblastic fibroma and ameloblastic fibrosarcoma closely resembled that in the bell stage without dental hard tissue formation, and MK localization in the basement membrane indicated signaling of reciprocal interaction between epithelial follicles and ectomesenchymal tissue. [9] Odontoma is regarded as a hamartoma and also mixed tumor histologically composed predominantly of dental hard tissues, i.e., dentin, enamel, and cementum. It contains also a small amount of odontogenic epithelium and ectomesenchyme. Its cellular elements include reduced ameloblasts, odontoblasts, and pulp cells after terminal differentiation. [10] In our study, the tumor cells adjacent to the dental hard tissues in odontoma showed no MK expression. In ameloblastic fibrodentinoma and fibro-odontoma, no MK localization occurred in the epithelial or mesenchymal cells adhering to the hard tissue, which were thought to take part in formation of the hard tissues. It is indicated that MK participates in the process of differentiation, and its expression decreases upon completion of differentiation and acquisition of function in odontogenic tumors, corresponding to the development of the mouse tooth. [9] Moreover, PCNA was frequently expressed in epithelial follicles and ectomesenchymal cells present in the high cellularity area of the odontogenic mixed tumor, and similar in distribution to that of MK expression. Co-expression of MK and PCNA suggested that MK is also involved in cell growth of odontogenic mixed tumors other than odontoma.
In conclusion, no difference in MK-positive rate and intensity was revealed between benign odontogenic tumors and their malignant counterparts, but our results suggest that the level of expression was correlated with local growth activity of odontogenic tumors. MK was frequently expressed in odontogenic mixed tumors except for odontoma, which contain tumor cells that have not completely differentiated. It is suggested that MK mediates epithelial-mesenchymal interactions in odontogenic mixed tumors as well as in physiological odontogenesis. 
